Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersEndocrinology, Diabetes & Metabolism Physician in Albuquerque, NM
NPI: 1154337756Primary Practice Location
UNM HOSPITAL
2211 Lomas Blvd Ne, Albuquerque, NM
Primary Employer
UNM Medical Group - 2211 Lomas
pathology.unm.edu
HQ Phone
Get David's Phone Numberphone_androidMobile
Get David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNM State Medical License
American Board of Internal Medicine
Endocrinology, Diabetes and Metabolism
American Board of Internal Medicine
Internal Medicine
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 36 | 59 |
Authors: Matthew Budoff, David Bluemke, Philip Raskin
Journal: JACC Cardiovasc Imaging
Publication Date: 2019-03-13
Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study.
Authors: Mikhail Kosiborod, David Bluemke, Maria Lopes-Virella, William Herman, Amisha Wallia
Journal: Diabetes Care
Publication Date: 2020-01-30
Cholesterol Review: A Metabolically Important Molecule.
Authors: Schade, David S, Shey, Lynda, Eaton, R Philip
Journal: Endocr Pract
Lead Sponsor: GRADE Study Group
Collaborators: Bristol-Myers Squibb, Merck Sharp & Dohme LLC, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Sanofi, National Heart, Lung, and Blood Institute (NHLBI), Novo Nordisk A/S, Centers for Disease Control and Prevention, Roche Diagnostics GmbH, Becton, Dickinson and Company
Intervention / Treatment: DRUG: Insulin (glargine), DRUG: Sulfonylurea (glimepiride), DRUG: DPP-4 inhibitor (sitagliptin), DRUG: GLP-1 receptor agonist (liraglutide)
